WELCOMING the Federal Court increase of the original fine for Reckitt Benckiser's (RB's) Nurofen fine from $1.7m to $6m after an appeal by the ACCC (PD 19 Dec), consumer group Choice says the penalty still doesn't go far enough.
Six years ago the watchdog awarded RB one of its famous 'Shonky Awards' for Nurofen marketing, with Choice saying the fine was "pocket change" compared to profits made by RB from the differentiated labelling of identical analgesics.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Dec 16
